Contents
In the BioTek reMEDys kickback settlement, the specialty pharmacy and its CEO agreed collectively to pay $20 million to resolve allegations involving waived patient copays, gifts and free services for referring physicians. The whistleblowers’ complaint describes what employees allegedly saw behind those benefits: collection efforts entered into a computer that never happened, referral alerts telling staff not to send bills, and a pharmacy executive posing as a member of a physician’s practice to get insurance claims paid.
BioTek, based in New Castle, Delaware, offered specialty drugs and infusion services. The Justice Department’s October 2, 2023 announcement described the joint settlement as based on the company and CEO’s ability to pay. It alleged that the CEO and others orchestrated the copay-waiver arrangement to protect BioTek’s revenue, and that the company supplied benefits to physicians to induce referrals. Former BioTek employees brought the False Claims Act case.
The government alleged that BioTek routinely waived Medicare and TRICARE patients’ copayments from at least August 2015 through May 2020 to induce them to buy its drugs and services. Many of those specialty drugs were expensive and carried large copays. According to the announcement, BioTek waived those charges without regard to whether the patients were experiencing financial hardship.
The Justice Department described Medicare’s cost-sharing requirements as a check on health care costs, and alleged that BioTek used waivers to keep those costs from deterring purchases. In that alleged arrangement, the patient saw a bill disappear while the pharmacy kept the business that generated insurance claims.
The physician side of the case concerned alleged referral payments through free practice support, along with gifts and dinners. The government alleged that BioTek offered free administrative and clinical services to induce referrals, particularly from a neurologist practicing in Bala Cynwyd, Pennsylvania. It also alleged that the physician knowingly solicited and accepted those benefits in exchange for referring patients.
The Anti-Kickback Statute reaches things of value offered or accepted in exchange for referrals paid by federal health care programs. In this case, the alleged physician kickbacks included work performed for the practice. The complaint says BioTek provided free insurance support to help get its specialty-drug claims paid, putting the alleged benefit inside the process that turned a prescription into pharmacy revenue.
The 2017 Journal of AHIMA article Busting Bad Medicine: A Call to Action Addressing Healthcare Fraud, Waste, and Abuse explains why physicians are valuable referral targets: they decide which drugs, specialists and suppliers patients use. It describes how kickbacks can distort those decisions, steer patients and disadvantage competitors. We see the unfair bargain in BioTek’s alleged arrangement: the practice gets free help, the pharmacy gets the referrals, and federal programs pay the resulting claims.
Free work also figured in the Alliance Family of Companies settlement. The government alleged that Alliance supplied free EEG interpretation reports that let referring physicians bill as though they had interpreted the tests. The work was different, but the practice-facing incentive was recognizable: a supplier allegedly did something valuable for the physician who could send it more business.
The BioTek whistleblowers’ complaint alleged that employees were told to create a collection history in CPR+, the system they used for account entries, before writing off unpaid balances. Their allegation puts the difference between the account entry and the work performed in plain words:
In many instances, Biotek employees were instructed to falsely make entries next to each unpaid balance in CPR+ to make it appear as though the Pharmacies attempted three collection efforts before writing off the balance. In reality, no collection efforts were made.
United States ex rel. Wyatt v. BioTek reMEDys, Inc., whistleblowers’ complaint, paragraph 73
The complaint describes employees making a balance look uncollectible without trying to collect it. A collection history manufactured for the write-off.
The complaint alleged that designating a patient for financial hardship assistance made the Biotek Foundation the responsible payer in CPR+. The balance was then written off without any funds being applied to the account. Changing the payer on a screen allegedly supplied the appearance of assistance without the payment.
One example concerned a beneficiary with more than $10,146 in unpaid cost sharing as of August 2019. The whistleblowers alleged that BioTek had made no effort to collect it and that the marketing executive told them to transfer the entire balance to the foundation and adjust it off. The named payer and the account’s payment history told different stories.
The complaint alleged that special CPR+ alerts flagged patients referred by selected physicians and reminded employees not to invoice them for cost sharing. It also alleged that financial hardship forms went directly to BioTek’s commissioned chief marketing officer, who approved waivers without discussing the patients’ circumstances or analyzing their finances.
In another example, the marketing executive allegedly approved assistance despite not knowing who the patient was, saying the referring physician would sign the necessary paperwork. When an employee raised concerns about unpaid balances, the complaint alleged, the CEO and marketing executive dismissed them and repeated the instruction not to invoice patients.
The free support allegedly extended to conversations with insurers about payment for infusion products and services. The whistleblowers described a marketing executive taking on the identity of someone inside the referring practice:
For example, on multiple occasions, [the marketing executive] posed as a member of [the referring physician’s] practice and performed peer to peer discussions with insurance companies on behalf of [the referring physician] in order to get claims for infusion products and services paid.
United States ex rel. Wyatt v. BioTek reMEDys, Inc., whistleblowers’ complaint, paragraph 92
The complaint puts that work beside its allegation that free administrative, clinical and insurance support rewarded physician referrals. For someone who handled those calls, the relevant connection is concrete: who spoke for the practice, whose products were being discussed, what the practice received for free, and which claims the work helped get paid.
The company and CEO’s agreement covered the alleged patient and physician inducements together. The neurologist separately paid $480,000, also based on ability to pay, to settle allegations that he solicited and accepted benefits for referrals.
The Justice Department credited a coordinated effort by its Civil Division’s Commercial Litigation Branch, Fraud Section, and the U.S. Attorney’s Offices for the Eastern District of Pennsylvania and the District of Delaware. The Department of Health and Human Services Office of the Inspector General, the Office of Inspector General for the Office of Personnel Management, and the Defense Criminal Investigative Service also took part.
The Justice Department said the former employees would receive $4 million collectively as their share of the BioTek and CEO settlement. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. The reward in this case began with employees who could describe how the accounts and referral arrangements worked inside the business.
The strongest evidence of the alleged arrangement joins the patient account to the referral relationship and the claim for payment. CPR+ entries, invoice alerts, hardship approvals, foundation transfers and insurer communications describe different parts of that chain. An account adjustment takes on a different meaning when the employee who made it also heard the instruction behind it.
If you saw a physician practice receive free support for referrals, or handled the pharmacy balances and insurance calls, speak with our whistleblower experts about the arrangement you saw. We build the case around your knowledge of the work and the money, and bring in healthcare fraud whistleblower lawyers who understand pharmacy and physician referral arrangements. We stay beside you through the process, working to build your strongest whistleblower case.